Ranking Alexa Global: # 3,402,430
Server:nginx/1.10.3 (Ubuntu...
X-Powered-By:Craft CMS
The main IP address: 138.68.118.209,Your server United States,Wilmington ISP:E.I. Dupont de Nemours and Company Inc. TLD:com CountryCode:US
The description :we are abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in....
This report updates in 13-Jun-2018
Created Date: | 1997-07-31 |
Changed Date: | 2016-05-12 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host abingworth.com. Currently, hosted in United States and its service provider is E.I. Dupont de Nemours and Company Inc. .
Latitude: | 39.728454589844 |
Longitude: | -75.537261962891 |
Country: | United States (US) |
City: | Wilmington |
Region: | Delaware |
ISP: | E.I. Dupont de Nemours and Company Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx/1.10.3 (Ubuntu) containing the details of what the browser wants and will accept back from the web server.
charset: | utf-8 |
X-Powered-By: | Craft CMS |
Transfer-Encoding: | chunked |
Set-Cookie: | CraftSessionId=eh422p8or16c7hvnb2e99bda15; path=/; secure; HttpOnly, CRAFT_CSRF_TOKEN=a36fef2902a7e7a96c554f7d442f13832a179243s%3A40%3A%22r39lMJrV2ffzIQJhPG5mVjgzvvR1wz5VXYAQCw%7EB%22%3B; path=/; secure; HttpOnly |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Vary: | Accept-Encoding |
Server: | nginx/1.10.3 (Ubuntu) |
Connection: | keep-alive |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate |
Date: | Tue, 12 Jun 2018 17:11:25 GMT |
Strict-Transport-Security: | max-age=15768000 |
Content-Type: | text/html; charset=utf-8 |
Content-Encoding: | gzip |
soa: | dns1.idp365.net. hostmaster.idp365.net. 2017100501 28800 1800 604800 3600 |
txt: | "0ed1fe018aa9fcfb8a27dc45f797ce9a4651bd343f" "v=spf1 include:spf.protection.outlook.com include:spf.messagelabs.com include:_netblocks.mimecast.com ~all" "MS=ms65036612" |
ns: | dns2.idp365.net. dns3.idp365.net. dns1.idp365.net. |
ipv4: | IP:138.68.118.209 ASN:14061 OWNER:DIGITALOCEAN-ASN - DigitalOcean, LLC, US Country:US |
mx: | MX preference = 10, mail exchanger = eu-smtp-inbound-2.mimecast.com. MX preference = 10, mail exchanger = eu-smtp-inbound-1.mimecast.com. |
about team strategy portfolio media contact investors about team strategy portfolio media investors contact life science investing we are abingworth, a transatlantic bioscience investment firm with a deep understanding of both the science and markets we invest in. explore our portfolio for over 30 years, abingworth has been working alongside entrepreneurs to develop their ideas into products that have a dramatic impact on health. with a broad transatlantic approach to backing innovation, we invest in drugs, devices and diagnostics from seed-stage start-ups to publicly traded companies. current news 7th june 2018 sutrovax announces $85m series c financing led by tpg growth 4th june 2018 dacomitinib shows more than seven-month improvement in overall survival compared to an established therapy in advanced nsclc with egfr-activating mutations read all news 1.9b raised in life science funds 64 ipos 11 life science funds raised the abingworth difference collaborate from decades of experience, we understand that one of the keys to building a great company is true partnership between entrepreneurs and their investors. innovate helping clever and committed people turn scientific breakthroughs into significant new advances in healthcare? we can’t imagine many more rewarding endeavours. create by harnessing advances in life sciences, we have built a succession of companies and helped to create one of the world’s most vibrant and important industries. our portfolio our longstanding commitment to partnering with entrepreneurs is evident throughout our portfolio. from t-cells to inflammasomes, gene editing to gene therapy, conjugate vaccines to novel antibiotics, we invest in a broad range of cutting-edge approaches. we also invest in small later-stage biotech companies, including some that are publicly traded, and in clinical co-development programmes with major pharmaceutical firms. view full portfolio our team collectively, the abingworth team has many decades of experience in almost every aspect of starting and growing a biotech company. whatever the challenge - creating your company, building your team, developing your strategy, advancing your programmes, negotiating with big pharma - our partners and advisors will be there to help you. meet the team latest updates one of the joys of working with small companies is seeing the speed that they make progress and we are always proud to share their achievements. read all news 7th june 2018 sutrovax announces $85m series c financing led by tpg growth 4th june 2018 dacomitinib shows more than seven-month improvement in overall survival compared to an established therapy in advanced nsclc with egfr-activating mutations 30th may 2018 crispr therapeutics and vertex provide update on fda review of investigational new drug application for ctx001 for the treatment of sickle cell disease legal privacy policy cookie policy terms & conditions © abingworth llp 2017 contact [email protected] +44 (0)20 7534 1500 38 jermyn street london sw1y 6dn social linkedin twitter vimeo close
https://www.abingworth.com/team/michael-bigham
https://www.abingworth.com/team/tim-haines
https://www.abingworth.com/portfolio/paratek-pharmaceuticals
https://www.abingworth.com/portfolio/crispr-therapeutics
https://www.abingworth.com/team/genghis-lloyd-harris
https://www.abingworth.com/investor
https://www.abingworth.com/team/sarah-shackelton
https://www.abingworth.com/pages/terms-of-use
https://www.abingworth.com/portfolio/sfj-pharmaceuticals-sfj-nsclc
https://www.abingworth.com/portfolio/gammadelta-therapeutics
https://www.abingworth.com/about
https://www.abingworth.com/portfolio/sutrovax
https://www.abingworth.com/investors
https://www.abingworth.com/team/luciana-castro
https://www.abingworth.com/tel:00442075341500
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: ABINGWORTH.COM
Registry Domain ID: 2087189_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.safenames.net
Registrar URL: http://www.safenames.net
Updated Date: 2016-05-12T11:31:42Z
Creation Date: 1997-07-31T04:00:00Z
Registry Expiry Date: 2018-07-30T04:00:00Z
Registrar: SafeNames Ltd
Registrar IANA ID: 447
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: DNS1.IDP365.NET
Name Server: DNS2.IDP365.NET
Name Server: DNS3.IDP365.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-05T11:59:56Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR SafeNames Ltd
SERVERS
SERVER com.whois-servers.net
ARGS domain =abingworth.com
PORT 43
TYPE domain
DOMAIN
NAME abingworth.com
CHANGED 2016-05-12
CREATED 1997-07-31
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
DNS1.IDP365.NET 217.19.248.20
DNS2.IDP365.NET 31.3.66.150
DNS3.IDP365.NET 207.228.239.80
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .